Owens & Minor Inc OMI
We take great care to ensure that the data presented and summarized in this overview for OWENS & MINOR INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding OMI
View all-
Black Rock Inc. New York, NY11.6MShares$168 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.81MShares$127 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY4.91MShares$71 Million1.43% of portfolio
-
Dimensional Fund Advisors LP Austin, TX4.8MShares$69.4 Million0.02% of portfolio
-
Coliseum Capital Management, LLC Rowayton, CT3.64MShares$52.7 Million5.63% of portfolio
-
State Street Corp Boston, MA3.06MShares$44.3 Million0.0% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA2.03MShares$29.3 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA1.71MShares$24.7 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA1.68MShares$24.3 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X01.55MShares$22.4 Million0.01% of portfolio
Latest Institutional Activity in OMI
Top Purchases
Top Sells
About OMI
Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States and internationally. It operates through two segments, Global Solutions and Global Products. The Global Solutions segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products and its proprietary products. This segment also offers services to healthcare providers, which include supplier management, analytics, inventory management, and clinical supply management; and various programs to provide logistics and marketing solutions to its suppliers. The Global Products segment manufactures and sources medical surgical products for the prevention of healthcare-associated infections across the acute and alternate site channels. This segments products portfolio includes sterilization wraps, surgical drapes and gowns, facial protection products, protective apparel, medical exam gloves, custom and minor procedure kits, and other medical products. It provides its products and services to multi-facility networks of healthcare providers, independent hospitals, surgery centers, physicians' practices, and networks of hospitals directly, as well as indirectly through third-party distributors. The company was founded in 1882 and is headquartered in Richmond, Virginia.
Insider Transactions at OMI
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Nov 21
2024
|
Jonathan A Leon EVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,282
-3.88%
|
$58,102
$11.82 P/Share
|
Nov 18
2024
|
Snehashish Sarkar |
SELL
Open market or private sale
|
Direct |
2,055
-3.55%
|
$24,660
$12.26 P/Share
|
Nov 15
2024
|
Snehashish Sarkar |
SELL
Payment of exercise price or tax liability
|
Direct |
1,196
-2.02%
|
$14,352
$12.27 P/Share
|
Sep 23
2024
|
Jonathan A Leon EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
42,933
+23.98%
|
-
|
Aug 22
2024
|
Jonathan A Leon EVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,500
-7.45%
|
$112,500
$15.83 P/Share
|
Aug 08
2024
|
Andrew G Long EVP, CEO P&HS |
SELL
Bona fide gift
|
Direct |
70,898
-31.88%
|
-
|
Jul 01
2024
|
Michael Wayne Lowry SVP, Corporate Controller |
BUY
Grant, award, or other acquisition
|
Direct |
19,202
+16.62%
|
-
|
Jul 01
2024
|
Jonathan A Leon EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,202
+16.02%
|
-
|
Jun 06
2024
|
Perry A Bernocchi EVP, CEO,. Patient Direct |
SELL
Open market or private sale
|
Direct |
20,015
-3.5%
|
$340,255
$17.48 P/Share
|
Jun 05
2024
|
Mark A Beck Director |
SELL
Open market or private sale
|
Direct |
9,344
-45.58%
|
$158,848
$17.25 P/Share
|
Jun 04
2024
|
Snehashish Sarkar |
SELL
Open market or private sale
|
Direct |
9,980
-14.44%
|
$169,660
$17.32 P/Share
|
Jun 03
2024
|
Alexander J Bruni EVP, CFO |
SELL
Open market or private sale
|
Direct |
10,568
-17.46%
|
$179,656
$17.76 P/Share
|
Jun 03
2024
|
Jennifer A Stone EVP, CHRO |
BUY
Grant, award, or other acquisition
|
Direct |
57,078
+50.0%
|
-
|
May 17
2024
|
Heath H Galloway EVP,General Counsel & CorpSecy |
SELL
Payment of exercise price or tax liability
|
Direct |
1,768
-3.22%
|
$33,592
$19.11 P/Share
|
May 17
2024
|
Heath H Galloway EVP,General Counsel & CorpSecy |
SELL
Open market or private sale
|
Direct |
2,052
-3.61%
|
$38,988
$19.06 P/Share
|
May 16
2024
|
Heath H Galloway EVP,General Counsel & CorpSecy |
SELL
Open market or private sale
|
Direct |
2,031
-3.45%
|
$40,620
$20.18 P/Share
|
May 15
2024
|
Jonathan A Leon EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,204
-3.78%
|
$60,876
$19.78 P/Share
|
May 15
2024
|
Andrew G Long EVP, CEO P&HS |
SELL
Payment of exercise price or tax liability
|
Direct |
27,372
-10.96%
|
$520,068
$19.78 P/Share
|
May 15
2024
|
Michael Wayne Lowry SVP, Corporate Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
2,077
-2.62%
|
$39,463
$19.78 P/Share
|
May 15
2024
|
Snehashish Sarkar |
SELL
Payment of exercise price or tax liability
|
Direct |
4,322
-5.89%
|
$82,118
$19.78 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 586K shares |
---|
Payment of exercise price or tax liability | 225K shares |
---|---|
Open market or private sale | 126K shares |
Bona fide gift | 75.9K shares |